Evaluation of Hepatic Function Using Gd-EOB-DTPA Enhanced Liver Magnetic Resonance Imaging

Trial Profile

Evaluation of Hepatic Function Using Gd-EOB-DTPA Enhanced Liver Magnetic Resonance Imaging

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs Gadoxetate disodium (Primary) ; Indocyanine green (Primary)
  • Indications Liver cirrhosis
  • Focus Diagnostic use
  • Most Recent Events

    • 14 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 10 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 08 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top